Ireland
--:--IST
Starting soon Not applicable

Effect of Knack Pelvic Floor Contraction on Sexual Dysfunction

NCT07145216 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2025-08-28

Condition(s) studied

Stress Urinary Incontinence (SUI)Sexual Dysfunction

Investigational drug(s) / intervention(s)

Interfrential stimulationKnack pelvic floor training

Interfrential stimulation: The participant will be positioned in semi-Fowler's position. Interferential therapy was given using the quadripolar method. Two electrodes were placed on the lower abdomen just above the outer half of the inguinal ligament, and another two on the inner aspect of the thigh near the origin of the adductor muscle. At the first treatment session, every participant will be examined for pelvic floor contraction by the finger palpation method using sterilized gloves to ensure the correct position of the electrodes. It will be set with intensity up to the tolerable limit of subjects, carrier frequency of 2000Hz, vector 900, rhythmic sweep frequency of 10-100Hz, and duration 20 minutes. Interferential therapy will be applied for the treatment procedure of all women in both groups for 20 minutes, 3days per week for 8 weeks.

Knack pelvic floor training: The knack technique (Fitz et al., 2021): * The patient will be instructed to lie in supine lying position with flexed knees. * Ask the patient to contract the pelvic floor muscles for 2-4 seconds and relax for 4 seconds for 15 repetitions with 3 sets before and during coughing or sneezing . * Contract the PFM before and during all daily activities involving effort, before and during coughing, sneezing, laughing, walking up and down stairs, jumping, running, bending, lifting a weight from the floor, holding a child, pushing furniture to prevent urine leakage. * Contract PFM and hold for 2-4 seconds, relax 4 seconds, with 3 sets of 15 repetitions.

Study summary

This study aims to investigate the effect of knack pelvic floor contraction on sexual dysfunction in females with stress urinary incontinence.

Eligibility

Sex
FEMALE
Min age
25 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: 1. Females with mild and moderate degrees of SUI according to Incontinence Severity Index score (mild: 1-2; and moderate: 3-4 scoring). 2. Their ages will range from 25 to 45 years old. 3. Their body mass index (BMI) will be less than 30 kg/m2. 4. They are multiparous women. 5. Females complain of sexual disorders related to SUI, identified by an FSFI score of less than 28.1 6. They have a sedentary lifestyle. Exclusion Criteria: 1. Severe degree of SUI. 2. Other types of urinary incontinence, such as urge urinary incontinence and mixed urinary incontinence. 3. Other neurological diseases such as myasthenia gravis and Parkinsonism. 4. History of pelvic fractures. 5. Menopausal women. 6. Females with pelvic organ prolapse (POP).

Primary outcome measure(s)

  • Assessment of pelvic floor muscle strength — 8 weeks
    PortablE biofeedback device will be used to assess pelvic floor muscle contraction. Each woman in both groups will be asked to count from 0 to 10 for 5 sets to achieve mental relaxation. Then, the area of the perineum will be cleaned with a disinfectant solution. The participant will insert the probe, which was covered with a condom and lubricated with hypoallergenic gel, into her vaginal cavity. The internal probe promotes proprioception and aids muscle awareness. The participants will be instructed to place the probe inside the vagina to a location where 0.5-1.0 cm of the probe is visible from the outside of the introitus. PFM strength will then be evaluated by a maximum voluntary contraction, as will be measured by squeeze pressure. Vaginal pressure testing will be performed with three repetitions of maximum voluntary contractions that each will be lasted for 3 s, with a 3-s rest between contractions. 2-minute rest break will then be taken, and the average score will be recorded.
  • Assessment of sexual function — 8 weeks
    The Arabic version of female sexual function Index score (FSFI) will be used to assess sexual function for all participating women in both groups before and after treatment program. All women in both groups will be asked to fill 5 domains of the questionnaire after explanation of them. The scoring system has a range of 2 to 36. According to Anis et al. (2011), a score above 28.1 indicated a good sexual life, whereas a score below 28.1 indicated reduced sexual function. The five categories of the questionnaire are severe (2-7.2), moderate (7.3-14.4), mild to moderate (14.5-21.6), mild (21.7-28.1 "cutoff point"), and no FSD (28.2-36)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Physical Therapy Giza Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07145216 on ClinicalTrials.gov ↗ ← All trials in Egypt